A comparative study on efficacy , safety and reduction of diabetic complications, with regimens of metformin, glimeperide, &vildagliptin vs metformin, Glimeperide, & dapagliflozin in type â?? 2 diabetic patients.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complicationsHealth Condition 2: null- Type 2 Diabetic
- Registration Number
- CTRI/2017/04/008424
- Lead Sponsor
- Siddhartha Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 435
Males and Females of age between 30-60 years
Type â?? 2 diabetics already on treatment but with uncontrolled blood sugars.
Type â?? 2 diabetics with hypertension.
Type â?? 2 diabetics with obesity.
Males and Females of age above 60 years .
Newly diagnosed cases of Type â?? 2. Type â?? 2 diabetics with other endocrinological disorders like hypo or hyperthyroidism, cushingâ??s syndrome and acromegaly, Type â?? 2 diabetics with pancreatic disorders like pancreatitis.
, Type â?? 2 Diabetics with acute complications.
Type â?? 2 Diabetics on drugs like thiazide diuretics, corticosteroids, oral contraceptive pills, protease inhibitors.
Other specific types of diabetes like MODY.
Type â?? 2 Diabetics with severe renal failure, heart failure, and hepatic failure.
Pregnant & lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method